1
0
0
News
Services von Trenzyme GmbH nach ISO zertifiziert, Trenzyme GmbH,...
www.pressebox.de
Trenzyme GmbH, Seit September ist die Trenzyme GmbH als einer der wenigen Dienstleister im Bereich Zelllinienentwicklung und Prote...
Kanton AargauKanton Aargau
www.ag.ch
— Konstantin Matentzoglu, CEO von Celonic, bezeichnet den Life Science Park Rheintal in der Mitteilung als eine „einzigartige“ und ...
Services von Trenzyme nach ISO zertifiziert -
www.bionity.com
Das Konstanzer Unternehmen entwickelte unter Leitung des zweiten Geschäftsführers Konstantin Matentzoglu in der Vergangenheit eine umfassende Palette an zellbiologischen Services, die höchsten Kundenanforderungen gerecht werden.
cytobox: Zelllinien-Herstellung im Rekord-Tempo
www.gesundheitsindustrie-bw.de
Bislang war die Produktion von Zelllinien mit einer Dauer von rund 14 Wochen sehr zeitintensiv. Durch ein weltweit einmaliges Format der Konstanzer Firma...
Netzwerk-Profile
Konstantin Matentzoglu, CEO at Celonic GroupData-lead.com
data-lead.com
CEO (Chief Executive Officer) at Celonic Group. See Konstantin Matentzoglu's contact information such as email address, phone number and linkedin page.
Konstantin MatentzogluBioSeek.eu
www.bioseek.eu
Created with Highcharts Date Count Number of publications by year Konstantin Matentzoglu Highcharts.com. Publication.
Celonic Management TeamCB Insights
www.cbinsights.com
4 Team Members. Celonic has 4 executives. Celonic's current Chief Executive Officer is Konstantin Matentzoglu.
Interessen
Fusion Antibodies Announces Collaboration with Celonic AG to offer...
www.prweb.com
Konstantin Matentzoglu added: “I am excited about this truly enabling partnership, which goes beyond a loose out-licensing/co-marketing deal. Celonic and Fusion Antibodies engage together and will offer highly aligned services to provide a safe and efficient development approach to clients worldwide.”.
MilliporeSigma Expands Celonic's Upstream Capabilities with Mobius®...
www.prnewswire.com
"For our biotech customers, each step towards market authorization boosts the valuation of their assets, and that's where Celonic's breadth of services has been instrumental in creating tremendous value for our partners," said Konstantin Matentzoglu, CEO, Celonic. "MilliporeSigma's Mobius® single-use ...
Mutation of HERC2 causes developmental delay with Angelman-like...
jmg.bmj.com
Monica Cubillos-Rojas,4 Konstantin Matentzoglu,3 Michael A Patton,1 Karin Wagner,5. Roselyn Coblentz,5 Debra L Ford,6 Deborah J G ...
Mutation of HERC2 causes developmental delay with ...BMJ
jmg.bmj.com
— ... Konstantin Matentzoglu Department of Biology and Konstanz Research School Chemical Biology, University of Konstanz, Konstanz, ...
Management & Beteiligungen
Konstantin Matentzoglu in MüllheimMoneyhouse
www.moneyhouse.ch
Konstantin Matentzoglu in Müllheim aus Deutschland ✓ hat ein Mandat bei Celonic AG - mit 4 Personen verbunden ✓ Letzte Änderung:
Business-Profile
Xing: Dr. Konstantin Matentzoglu - CEO - Celonic AG | XING
Berufserfahrung, Kontaktdaten, Portfolio und weitere Infos: Erfahren Sie mehr – oder kontaktieren Sie Dr. Konstantin Matentzoglu direkt bei XING.
Private Homepages
Konstantin Matentzoglu's Email & Phone - Celonic GroupContactOut
contactout.com
Konstantin Matentzoglu works in the Biotechnology industry. About Konstantin Matentzoglu. Summary. Member Of The Supervisory Board @ Polpharma ...
Ausbildung
Caracterización funcional de la interacción de la Dipòsit Digital
diposit.ub.edu
with Angelman-like features. Gaurav V Harlalka,1 Emma L Baple,1 Harold Cross,2 Simone Kühnle,3. Monica Cubillos-Rojas,4 Konstantin Matentzoglu,3 Michael A Patton,1 Karin Wagner,5. Roselyn Coblentz,5 Debra L Ford,6 Deborah J G Mackay,7 Barry A Chioza,1. Martin Scheffner,3 Jose Luis Rosa,4 Andrew H Crosby1.
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice ...King's College London
kclpure.kcl.ac.uk
von AG Uren · · Zitiert von: 204 — Anthony G Uren, Jaap Kool, Konstantin Matentzoglu, Jeroen de Ridder, Jenny Mattison, Miranda van Uitert, Wendy Lagcher, Daoud Sie, ...
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice...
kclpure.kcl.ac.uk
author = "Uren, {Anthony G} and Jaap Kool and Konstantin Matentzoglu and {de Ridder}, Jeroen and Jenny Mattison and {van Uitert}, Miranda and Wendy ...
Dokumente zum Namen
BIOPHARMA BUSINESS EXCELLENCEオリエンタル酵母工業
www.oyc.co.jp
Basel, Switzerland (HQ). Stein, Switzerland. Heidelberg, Germany. Dr. Konstantin Matentzoglu. Private, JRS Group, Germany. ABOUT US.
Insertional Mutagenesis in Mice Deficient for p15 Ink4b , p aacrjournals.org
aacrjournals.org
von J Kool · · Zitiert von: 39 — Konstantin Matentzoglu;. Konstantin Matentzoglu. Authors' Affiliations: 1Division of Molecular Genetics, The Centre of Biomedical Genetics, ...
Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies...
www.scienceopen.com
Authors: Anthony G. Uren,, Jaap Kool,, Konstantin Matentzoglu,, Jeroen de Ridder,, Jenny Mattison, Miranda van Uitert, Wendy Lagcher, Daoud ...
Wissenschaftliche Veröffentlichungen
Angelman syndrome: advancing the research frontier of...
jneurodevdisorders.biomedcentral.com
Using the more traditional, but still powerful, approach of yeast-two-hybrid screening and affinity proteomics, Konstantin Matentzoglu and his ...
Konstantin Matentzoglu – ScienceOpen
www.scienceopen.com
Summary p53 and p19ARF are tumor suppressors frequently mutated in human tumors. In a high-throughput screen in mice for mutations collaborating with ...
KOPS.Mutation of HERC2 causes developmental delay with Angelman-like...
kops.uni-konstanz.de
Mutation of HERC2 causes developmental delay with ... CUBILLOS-ROJAS, Konstantin MATENTZOGLU, ... HERC2 causes developmental delay with Angelman-like ...
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice...
kops.uni-konstanz.de
UREN, Anthony G., Jaap KOOL, Konstantin MATENTZOGLU, Jeroen de RIDDER, Jenny MATTISON, Miranda van UITERT, Wendy LAGCHER, Daoud SIE, Ellen TANGER, Tony …
Veröffentlichungen allgemein
HBIO FORUM FINAL PROGRAMME_Nov issuu
issuu.com
— Konstantin Matentzoglu, Celonic Switzerland A leading Greek pharma (ELPEN), our investment in R&D and a new Research Institute: a model ...
Consistently delivering outperforming cell lines leveraging ...trio-biotech.com
www.trio-biotech.com
Dr. Konstantin Matentzoglu. Private, JRS Group, Germany. ABOUT US. GMP production. Employees: Heidelberg. 2. GERMANY. Basel. Development.
and p53-Deficient Mice Identifies Cancer Genes and Their ...ResearchGate
www.researchgate.net
Anthony Uren · Jaap Kool · Konstantin Matentzoglu · Jeroen De Ridder · Anton Berns · Download · Document S1. Seven Figures and Six Tables.
Artikel & Meinungen
Konstantin Matentzoglu - CEO, Celonic, SwitzerlandPharmaBoardroom
pharmaboardroom.com
— CEO of Swiss biologics CDMO Celonic, Konstantin Matentzoglu, explains how the company attracts talented and experienced staff and what makes ...
BAU.DE - Forum - Estrich und Bodenbeläge : Kunstharzboden...
bau.net
BAU.DE - Forum - Estrich und Bodenbeläge : Kunstharzboden selbst verlegen
Konstantin Matentzogluinospin
www.inospin.com
Konstantin Matentzoglu. Global citimpact: GM at Trenzyme GmbH. Profile · Groups · Memberships. Order By: Last Active, Most Members, Newly Created ...
Celonic agrees cooperation to combat coronavirusBasel Area Business & Innovation
baselarea.swiss
— ... in the fight against this global pandemic, according to Konstantin Matentzoglu, CEO of Celonic, who was quoted in the press release.
Sonstiges
EP A1 - Composition for use in the treatment of Angelman...
patents.google.com
The invention is related to a composition for use in the treatment of Angelman syndrome and/or autism spectrum disorder, wherein the composition comprises a...
Celonic to Boost its Cell & Gene Therapy Production with ...Yahoo
uk.finance.yahoo.com
— ... Gene space and enable us to offer large-scale ATMP GMP manufacturing from early 2022," said Konstantin Matentzoglu, CEO of Celonic AG.
Konstantin Matentzoglu aus Müllheim - Manager-ProfilCompanyHouse
www.companyhouse.de
Werdegang von Konstantin Matentzoglu aus Müllheim: Geschäftsführer der Celonic Deutschland Verwaltung GmbH, früher Geschäftsführer der Trenzyme GmbH.
Konstantin Matentzoglu, Müllheim (DE)Business-Monitor
business-monitor.ch
Vollständige Informationen des Handelsregisters für Konstantin Matentzoglu in Müllheim (DE), Führungsaufgaben, Karriereverlauf, SHAB, Netzwerk,...
Konstantin Matentzoglu (kmatentzoglu) - ProfilePinterest.de
www.pinterest.de
Sieh dir an, was Konstantin Matentzoglu (kmatentzoglu) auf Pinterest, der weltweit größten Sammlung von Ideen, entdeckt hat.
Konstantin Theodor Matentzoglu, Müllheim
www.northdata.de
Geschäftsführer: Konstantin Matentzoglu · Gesellschaftsvertrag. Die Informationen dieser Seite wurden durch Analyse öffentlicher Quellen mittels eines voll-automatischen Algorithmus erstellt, und können teils oder weitgehend fehlerbehaftet sein. Die öffentlichen Quellen stehen erst seit vollständig in elektronischer ...
Konstantin Matentzoglu - Meersburg - Online-Handelsregister Auskunft
www.online-handelsregister.de
In Zusammenhang mit Trenzyme GmbH,
Konstantin Theodor Matentzoglu, MüllheimNorth Data
www.northdata.de
... Celonic AG The Biosimilars Group GmbH (i.L.) Renato Wirthner Josef Otto Rettenmaier Harald Klein Konstantin Matentzoglu aktuell vormals ...
About us DEPrediction biosciences
predict.net
Konstantin Matentzoglu – Ph.D. Generaldirektor, Celonic AG. MANAGEMENT. Cornelius Diamond. President. Dr. Diamond hält einen Doktortitel in Biophysik von ...
BPI Theater @ BIO 2019BioProcess International
bpi.bioprocessintl.com
BioProcess Insider BPI Theater @ BIO Interviews — Tuesday Featuring Konstantin Matentzoglu, Chief Executive Officer of the CELONIC Group ...
Celonic Acquires Glycotope's Bio-manufacturing FacilityWorld Pharma Today
www.worldpharmatoday.com
Dr. Konstantin Matentzoglu, Celonic's Chief Executive Officer, said “With on-boarding of almost two decades of invaluable experience in optimization of ...
They have the super cell
www.gesundheitsindustrie-bw.de
In the “Year of Science”, which is being celebrated in the city of Constance in 2009, the company Trenzyme, located in the Constance industrial park, is a...
Celonic CEO and key executive teamCraft.co
craft.co
Celonic's CEO is Konstantin Matentzoglu. Other executives include Vikalp Mohan, COO; Harald Klein, CFO and 1 others. See the full leadership team at Craft.
analytica 2010: All events in detail analytica Conference - PDF Free...
docplayer.org
Download "analytica 2010: All events in detail analytica Conference" Download Document. Tomas Koch; ... AAC Infotray AG Dr. Konstantin Matentzoglu, ...
Trenzyme receives ISO certification
www.gesundheitsindustrie-bw.de
The Trenzyme GmbH has set another milestone as a first class service provider for the pharma and life science industry.
Celonic Acquires Glycotope’s Bio-manufacturing Facility | World...
www.worldpharmatoday.com
Celonic AG, a leading global biologics development and manufacturing services provider, and Glycotope, a clinical stage immune-oncology company, today announced
Celonic planning to open production site in SteinS-GE
www.s-ge.com
In the press release, Konstantin Matentzoglu, CEO of Celonic, describes the Life Science Park Rheintal as a “unique” and “state-of-the-art” facility.
Celonic's Competitors, Revenue, Number of Employees ...Owler
www.owler.com
Celonic CEO: Konstantin Matentzoglu. CEO. Konstantin Matentzoglu. CEO Approval Rating Weigh In HeidelbergBaden-Württemberg.
Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a,...
www.lifescience.net
Jaap Kool, Anthony G Uren, Carla P Martins, Daoud Sie, Jeroen de Ridder, Geoffrey Turner, Miranda van Uitert, Konstantin Matentzoglu, ...
Celonic Acquires Glycotope’s Biomanufacturing Facility | BioPharm...
www.biopharminternational.com
CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.
Verwandte Suchanfragen zu Konstantin Matentzoglu
| Gene Therapy Martin Scheffner Harald Klein | Jaap Kool Konstantin Theodor Matentzoglu Soenke Brunswieck | Albrecht Fritzsche Silvia Matentzoglu |
Personen Vorname "Konstantin" (6049) Name "Matentzoglu" (11) |
sortiert nach Relevanz / Datum